Ita-as, Dante U.

HRN: 26-51-57  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2025
CEFTRIAXONE 1G (VIAL)
07/27/2025
08/02/2025
IV
2g
OD
CAP MR
Remove - Pending Acceptance
07/27/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/27/2025
08/02/2025
IV
600 Mg
Q6
Decubitus Ulcer
Remove - Pending Acceptance
07/27/2025
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
07/27/2025
08/02/2025
TOPICAL
1g
Twice A Day
Decubitous Ulcer
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: